Related Experiment Videos
Levetiracetam in pediatrics.
1Neurology Division, Bambino Gesù Children's Hospital, Rome, Italy. vigevano@opbg.net
Journal of Child Neurology
|March 30, 2005
Summary
Levetiracetam is an effective antiepileptic drug for children, showing promise for generalized epilepsy. While generally well-tolerated, careful titration is advised to manage potential behavioral side effects and seizure increases.
Area of Science:
- Pediatric Neurology
- Pharmacology
- Epileptology
Background:
- Levetiracetam's efficacy and tolerability are established in adults.
- Limited data exists on its use in pediatric populations.
- This review synthesizes international literature on levetiracetam's pediatric indications.
Purpose of the Study:
- To identify and report potential indications for levetiracetam in childhood epilepsy.
- To consolidate existing evidence on levetiracetam's use in pediatric patients.
Main Methods:
- Systematic review of international literature.
- Analysis of studies on levetiracetam's efficacy and tolerability in children.
- Evaluation of treatment outcomes for various epilepsy types.
Main Results:
- Levetiracetam demonstrates efficacy in partial and generalized epilepsy.
- In resistant partial epilepsy, response rates are 64%, with 8-23% seizure-free.
- Effective for photosensitivity, epileptic, and nonepileptic myoclonus.
- Most frequent side effects are behavioral, particularly in patients with prior issues.
- Slow titration can mitigate seizure increase adverse reactions.
- Recommended pediatric doses are 130-140% of adult doses.
Conclusions:
- Levetiracetam exhibits a broad spectrum of action in pediatric epilepsy.
- The drug is generally well-tolerated in children.
- Efficacy against generalized epilepsy is particularly promising for childhood use.